Old Web
English
Sign In
Acemap
>
Paper
>
PRECLINICAL ACTIVITY OF THE NOVEL ORAL DUAL BET-CBP/P300 INHIBITORS, NEO1132 AND NEO2734, IN ACUTE MYELOID LEUKEMIA: PS967
PRECLINICAL ACTIVITY OF THE NOVEL ORAL DUAL BET-CBP/P300 INHIBITORS, NEO1132 AND NEO2734, IN ACUTE MYELOID LEUKEMIA: PS967
2019
Martiañez T. Canales
N. van Gils
Eline Vermue
Arjo P Rutten
Fedor Denkers
T. van der Deure
F. Giles
Linda Smit
Keywords:
Cancer research
Myeloid leukemia
Medicine
cbp p300
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]